All Type of News


Dong-A signs DA-9701 export deals

Dong-A Pharmaceutical Co. said Wednesday that it has inked a memorandum of understanding with Pahang (Malaysia) and Landson (Indonesia) for its in-house developed DA-9701, a new prokinetic agent formulated with Pharbi...

Local company to roll out new premature ejaculation drug

Jinyang Pharmaceutical and CTC Bio have recently announced that they will carry out Phase 3 clinical trials for the development of premature ejaculation (PE) drug. The results of Phase 2 study demonstrated the safe...

Blue Apple campaign highlights health of prostate

The Korean Urological Association (KUA) said Wednesday that it will launch a Blue Apple public information campaign to enhance the public awareness to the health of prostate. The campaign focuses on the prevention ...

Foreign hyperlipemia drugs increase market share

Foreign-made hyperlipemia medicines showed sustained growth of the sector’s domestic sales in February, an industry report showed recently. According to Shinhan Investment Corp., Pfizer’s Lipitor and AstraZeneca’s ...

Three ministries to invest 530 billion won until 2009

Korea is pushing a 1-trillion won national project to develop 10 new drugs by 2019 in the pharmaceutical sector that would lead the nation’s growth in future decades. The government has recently set out long-term r...

61% of hospitals participate in DUR program

Health Insurance Review and Assessment Service (HIRA) says 39,813 hospitals nationwide are joining Drug Utilization Review (DUR) program, which accounts for 60.7 percent of total medical institutions. The DUR parti...

Knee joint surgery down, PET scans down

Korea’s knee or spine replacement surgery has been on the gradual increase for the recent three years, but PET scan for the diagnosis of cancer progress plummeted last year due to the intensive screening program, acco...

Whanin to launch new natural drug preventing Alzheimer’s disease

Whanin Pharmaceutical says it has completed Phase III clinical trial for the natural extract INM-176 (Angelica gigas), an effective drug for the prevention and treatment of Alzheimer’s disease. “If the natural drug...

Fees on MRI, CT scans to be reduced from May

Medical fee for MRI, CT or PET cans will be lowered from May as part of efforts to discourage hospitals or clinics from resorting to ordering more tests, even when they’re not necessary, it was learned Monday. “Mos...

EPS of pharmaceutical firms analyzed

The average earnings per share (EPS) of 29 pharmaceutical companies was 2,141 won last year, down 391 won from 2,532 won, according to Yakup Shinmoon web site (www.yakup.com). EPS is the portion of a company's prof...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.